{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:10:38Z","timestamp":1793394638917,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.xkme.2024.100879","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:49:12Z","timestamp":1721882952000},"page":"100879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hyperkalemia Incidence in Patients With Non-Dialysis Chronic Kidney Disease: A Large Retrospective Cohort Study From United States Clinical Care"],"prefix":"10.1016","volume":"6","author":[{"given":"Sascha","family":"van Boemmel-Wegmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schuchhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Beeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Edfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9888","key":"10.1016\/j.xkme.2024.100879_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"10159","key":"10.1016\/j.xkme.2024.100879_bib2","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.xkme.2024.100879_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.ackd.2017.06.004","article-title":"Hyperkalemia and hypokalemia in CKD: prevalence, risk factors, and clinical outcomes","volume":"24","author":"Gilligan","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.xkme.2024.100879_bib4","article-title":"Management of chronic hyperkalemia in patients with chronic kidney disease: an old problem with news options","volume":"8","author":"Morales","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.xkme.2024.100879_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","volume":"4","author":"Rosano","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2024.100879_bib6","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1093\/ndt\/gfz206","article-title":"Hyperkalemia: pathophysiology, risk factors and consequences","volume":"34","author":"Hunter","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2024.100879_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrneph.2012.281","article-title":"Improving the efficacy of RAAS blockade in patients with chronic kidney disease","volume":"9","author":"Lambers Heerspink","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2024.100879_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2215\/CJN.13541021","article-title":"Hyperkalemia with mineralocorticoid receptor antagonist use in people with CKD: understanding and mitigating the risks","volume":"17","author":"Epstein","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2024.100879_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ckj\/sfab243","article-title":"How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies","volume":"15","author":"Humphrey","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.xkme.2024.100879_bib10","article-title":"Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2\u00b74 million patients from 11 countries: the CaReMe CKD study","volume":"20","author":"Sundstr\u00f6m","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"13","key":"10.1016\/j.xkme.2024.100879_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s40265-021-01555-5","article-title":"Hyperkalemia in chronic kidney disease in the new era of kidney protection therapies","volume":"81","author":"Valdivielso","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.xkme.2024.100879_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000493395","article-title":"Chronic hyperkalemia in cardiorenal patients: risk factors, diagnosis, and new treatment options","volume":"9","author":"Di Lullo","year":"2019","journal-title":"Cardiorenal Med"},{"issue":"1","key":"10.1016\/j.xkme.2024.100879_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"issue":"9","key":"10.1016\/j.xkme.2024.100879_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.xkme.2024.100879_bib17","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12325-023-02482-5","article-title":"Patient management and clinical outcomes associated with a recorded diagnosis of stage 3 chronic kidney disease: the REVEAL-CKD study","volume":"40","author":"Tangri","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.xkme.2024.100879_bib18","series-title":"Chronic Kidney Disease Often Undiagnosed in Medicare Beneficiaries. CMS OMH Data Highlight No. 20","author":"Maciejewski","year":"2020"},{"issue":"2","key":"10.1016\/j.xkme.2024.100879_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/j.ajkd.2020.01.007","article-title":"CKD awareness among US adults by future risk of kidney failure","volume":"76","author":"Chu","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2024.100879_bib20","series-title":"A\u00a0R Project for Statistical Computing","year":"2022"},{"issue":"3","key":"10.1016\/j.xkme.2024.100879_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213192","article-title":"Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: a general practice-based, observational study","volume":"14","author":"Jun","year":"2019","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.xkme.2024.100879_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/pds.1923","article-title":"Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril","volume":"19","author":"Johnson","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.xkme.2024.100879_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/20543581211017408","article-title":"Initial and recurrent hyperkalemia events in patients with CKD in older adults: a population-based cohort study","volume":"8","author":"Sriperumbuduri","year":"2021","journal-title":"Can J Kidney Health Dis"},{"issue":"11","key":"10.1016\/j.xkme.2024.100879_bib24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/imj.14970","article-title":"Serum potassium abnormalities in chronic kidney disease: prevalence, patient characteristics and clinical outcomes","volume":"51","author":"Brookes","year":"2021","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.xkme.2024.100879_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000437151","article-title":"Serum potassium, end-stage renal disease and mortality in chronic kidney disease","volume":"41","author":"Nakhoul","year":"2015","journal-title":"Am J Nephrol"},{"issue":"17","key":"10.1016\/j.xkme.2024.100879_bib26","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/archinternmed.2009.284","article-title":"Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy","volume":"169","author":"Weinberg","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.xkme.2024.100879_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between serum potassium and outcomes in patients with reduced kidney function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"17","key":"10.1016\/j.xkme.2024.100879_bib28","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and\u00a0adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis","volume":"39","author":"Kovesdy","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.xkme.2024.100879_bib29","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.ekir.2022.05.033","article-title":"Low adherence to Kidney Disease: Improving Global Outcomes 2012 CKD clinical practice guidelines despite clear evidence of utility","volume":"7","author":"James","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.xkme.2024.100879_bib30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.mayocp.2020.07.037","article-title":"Adherence to chronic kidney disease screening guidelines among patients with type 2 diabetes in a US administrative claims database","volume":"96","author":"Folkerts","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.xkme.2024.100879_bib31","article-title":"Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing","volume":"12","author":"Christofides","year":"2021","journal-title":"J\u00a0Prim Care Community Health"},{"issue":"1","key":"10.1016\/j.xkme.2024.100879_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"Clase","year":"2020","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2024.100879_bib33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.mayocp.2020.06.014","article-title":"Clinical management of hyperkalemia","volume":"96","author":"Palmer","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"3-4","key":"10.1016\/j.xkme.2024.100879_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000369138","article-title":"Predictors of hyperkalemia risk after hypertension control with aldosterone blockade according to the presence or absence of chronic kidney disease","volume":"128","author":"Gwoo","year":"2014","journal-title":"Nephron Clin Pract"},{"issue":"44","key":"10.1016\/j.xkme.2024.100879_bib35","first-page":"3498","article-title":"[Development of a hyperkalemia risk assessment model for patients with chronic kidney disease]","volume":"100","author":"Mei","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.xkme.2024.100879_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejim.2013.11.007","article-title":"Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review","volume":"25","author":"Mavrakanas","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.xkme.2024.100879_bib37","first-page":"459","article-title":"Long-term effects of spironolactone on kidney function and hyperkalemia-associated hospitalization in patients with chronic kidney disease","volume":"7","author":"Yang","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.xkme.2024.100879_bib38","article-title":"Use of mineralocorticoid receptor antagonists in patients with heart failure and comorbid diabetes mellitus or chronic kidney disease","volume":"6","author":"Cooper","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.xkme.2024.100879_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059524000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059524000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:22:45Z","timestamp":1728296565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059524000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2590059524000906"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2024.100879","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperkalemia Incidence in Patients With Non-Dialysis Chronic Kidney Disease: A Large Retrospective Cohort Study From United States Clinical Care","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2024.100879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100879"}}